NCT01158183View on ClinicalTrials.gov

Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis

CompletedOBSERVATIONAL
Enrollment

226

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions
DRUG

BAY86-5046_Interferon-beta-1b

Electronic questionnaires

Trial Locations (27)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT01158183 - Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis | Biotech Hunter | Biotech Hunter